sglt2 inhibitor glp 1 agonist combination Concomitant use of inhibitors and GLP-1 receptor agonists in patients with heart failure | Cardiovascular Diabetology – Endocrinology Reports Renal outcomes of SGLT2 inhibitors

The brain was removed, then post-fixed with the fixative (4, overnight), and embedded in Tissue-Tek OCT-compound (Sakura Finetek, Tokyo, Japan)

Homocysteine is a thiol-containing amino acid, which suffers two major metabolic fates: remethylation catalyzed by methionine synthase (MS), methylenetetrahydrofolate reductase (MTHFR) or betaine-homocysteine methyltransferases (BHMT) and transsulfuration catalyzed by cystathionine -synthase (CBS) leading to cystathionine [3] (Figure 1)

Personalised Package A personalised package is a tailored combination of treatments designed to address your unique aesthetic goals and enhance your natural features

10.1124/jpet.104.073890 25

Systemic side effects are not well-documented in human studies at therapeutic doses